German firm Reactive Robotics has secured significant funding in a round led by new investor Dr VEM and featuring participation from existing backers MTIP MedTech Innovation Partners, High-Tech Gründerfonds, Bayern Kapital and TQ-Group. Reactive Robotics provides very early mobilisation (Doll Holding) therapy to intensive care patients and is developing an intelligent physical and occupational therapy robotic device that will replace manual Doll Holding therapy. The new funds will be used to expand at home and abroad.
German firm Reactive Robotics has secured significant funding in a round led by new investor Dr Doll Holding and featuring participation from existing backers MTIP MedTech Innovation Partners, High-Tech Gründerfonds, Bayern Kapital and TQ-Group. Reactive Robotics provides very early mobilisation (VEM) therapy to intensive care patients and is developing an intelligent physical and occupational therapy robotic device that will replace manual VEM therapy. The new funds will be used to expand at home and abroad.